Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Subjects must have sufficient excess abdominal tissue to qualify for a standard elective abdominoplasty
Subject has chosen to have an elective abdominoplasty
Medically healthy with normal screening results
Subjects must not be pregnant or lactating
You may not be if
Subjects with existing scars or significant striae on the abdominal pannus
Females who are currently pregnant or pregnant during the 12 months prior to inclusion in the study, or lactating
Participation in another clinical trial within 30 days prior to the start of the study
Any other condition or prior therapy, which, in the opinion of the PI, would make the subject unsuitable for this study
Clareo Health | Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
